Administration of subtumor regression dosage of TNF-α to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule
- 1 April 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (7) , 499-507
- https://doi.org/10.1038/sj.gt.3301429
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 18 references indexed in Scilit:
- Exogenous Recombinant Human IL-12 Augments MHC Class I Antigen Expression on Human Cancer Cells in vitro.The Tohoku Journal of Experimental Medicine, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Augmented Antitumor Effects of Killer Cells Induced by Tumor Necrosis Factor Gene-Transduced Autologous Tumor Cells from Gastrointestinal Cancer PatientsHuman Gene Therapy, 1996
- Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in miceInternational Journal of Cancer, 1995
- Efficacy of tnf-α gene-transduced tumor cells in treatment of establishedin vivo tumorInternational Journal of Cancer, 1995
- Augmented Systemic Immunity in Mice Implanted with Tumor Necrosis Factor‐α Gene‐transduced Meth‐A CellsJapanese Journal of Cancer Research, 1994
- Human Tumor–infiltrating Lymphocytes Transfected with Tumor Necrosis Factor Gene Could Augment Cytotoxicity to Autologous Tumor CellsJapanese Journal of Cancer Research, 1991
- HLA‐class‐I and‐class‐II expression on renal tumor xenografts and the relation to sensitivity for α‐IFN, γ‐IFN and TNFInternational Journal of Cancer, 1991
- Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancyEuropean Journal of Cancer and Clinical Oncology, 1991
- Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cellsClinical and Experimental Immunology, 1990